Spots Global Cancer Trial Database for A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Official Title: A SINGLE-ARM OPEN-LABEL INTERNATIONAL MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF SUNITINIB MALATE (SU011248, SUTENT (REGISTERED)) IN PATIENTS WITH PROGRESSIVE ADVANCED METASTATIC WELL-DIFFERENTIATED UNRESECTABLE PANCREATIC NEUROENDOCRINE TUMORS
Study ID: NCT01525550
Interventions
Study Description
Brief Summary: The purpose of this study is to confirm the safety and efficacy of sunitinib in subjects with unresectable pancreatic neuroendocrine tumors.
Detailed Description: This study is being conducted to meet regulatory post-marketing commitments.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Univeristy of California, Orange, California, United States
Columbia University Medical Center, New York, New York, United States
Barwon Health - University Hospital Geelong, Geelong, Victoria, Australia
Cliniques Universitaires Saint-Luc, Gastroenterologie, Bruxelles, Brussels Gewest, Belgium
China-Japan Friendship Hospital, Beijing, Beijing, China
307 Hospital of PLA, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Nanjing Bayi Hospital, Nanjing, Jiangsu, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Fudan University Shanghai Cancer Center, Shanghai, , China
Zhongshan Hospital Fudan University, Shanghai, , China
Masarykuv onkologicky ustav, Brno, , Czechia
Fakultni poliklinika, Praha 2, , Czechia
Vseobecna Fakultni Nemocnice v Praze, Praha 2, , Czechia
Hôpital Beaujon, Clichy Cedex, , France
Semmelweis Egyetem/II. Sz. Belgyogyaszati Klinika, Budapest, , Hungary
Tata Memorial Hospital, Mumbai, Maharashtra, India
IEO Istituto Europeo di Oncologia, IRCCS, Milano, , Italy
Kyushu University Hospital, Fukuoka-shi, Fukuoka, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Oslo Universitetssykehus HF, Rikshospitalet, Oslo, , Norway
Centrul de Oncologie Sf. Nectarie, Craiova, Dolj, Romania
Institutul Clinic Fundeni, Centrul de Gastroenterologie si Hepatologie, Bucuresti, , Romania
Narodny Onkologicky ustav, Bratislava, , Slovakia
Wits Clinical Research, Johannesburg, Gauteng, South Africa
Hospital Universitario Madrid Sanchinarro - Centro Integral Oncológico Clara Campal (CIOCC), Madrid, , Spain
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
